| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |